Skip to main content
Clinical Trials/NCT02973555
NCT02973555UnknownNot Applicable

Can Platelet-rich Plasma (PRP) Promote Endometrial Growth and Improve Pregnancy Outcome of Patients With Thin Endometrium Undergoing Assisted Reproductive Technology (ART) Treatments?

Hadassah Medical Organization1 site in 1 country50 target enrollmentStarted: January 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
50
Locations
1
Primary Endpoint
endometrial thickness >7mm

Study Overview

Brief Summary

Platelet-rich plasma (PRP) may promote the endometrial growth and improve pregnancy outcome of patients with thin endometrium undergoing ART treatments.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 54 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Women undergoing a frozen thawed embryo transfer cycle with poor endometrial response to estrogen (< 7 mm) after at least two standard preparation protocols, of which one was canceled due to thin endometrium

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

endometrial thickness >7mm

Time Frame: 1 month

Secondary Outcomes

  • Positive serum pregnancy test(14 days post embryo transfer)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials